{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T07:18:26Z","timestamp":1782890306906,"version":"3.54.5"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T00:00:00Z","timestamp":1537488000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1038\/s41371-018-0112-8","type":"journal-article","created":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T07:36:51Z","timestamp":1537515411000},"page":"57-61","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["High efficiency of the aldosterone-to-renin ratio in precisely detecting primary aldosteronism"],"prefix":"10.1038","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3271-0352","authenticated-orcid":false,"given":"Wenjia","family":"Gan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dubo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenrong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinning","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,21]]},"reference":[{"key":"112_CR1","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/j.1365-2265.2007.02775.x","volume":"66","author":"WF Young","year":"2007","unstructured":"Young WF. Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol (Oxf). 2007;66:607\u201318.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"112_CR2","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1046\/j.1440-1681.2001.03523.x","volume":"28","author":"M Stowasser","year":"2001","unstructured":"Stowasser M. New perspectives on the role of aldosterone excess in cardiovascular disease. Clin Exp Pharmacol Physiol. 2001;28:783\u201391.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"112_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1440-1681.1994.tb02519.x","volume":"21","author":"RD Gordon","year":"1994","unstructured":"Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC. High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol. 1994;21:315\u20138.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"112_CR4","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1210\/jc.2003-031337","volume":"89","author":"P Mulatero","year":"2004","unstructured":"Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab. 2004;89:1045\u201350.","journal-title":"J Clin Endocrinol Metab"},{"key":"112_CR5","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","volume":"48","author":"GP Rossi","year":"2006","unstructured":"Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006;48:2293\u2013300.","journal-title":"J Am Coll Cardiol"},{"key":"112_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15548627.2015.1100356","volume":"12","author":"DJ Klionsky","year":"2016","unstructured":"Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016;12:1\u2013222.","journal-title":"Autophagy"},{"key":"112_CR7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.tem.2005.02.010","volume":"16","author":"G Rossi","year":"2005","unstructured":"Rossi G, Boscaro M, Ronconi V, Funder JW. Aldosterone as a cardiovascular risk factor. Trends Endocrinol Metab. 2005;16:104\u20137.","journal-title":"Trends Endocrinol Metab"},{"key":"112_CR8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.tem.2008.01.006","volume":"19","author":"GP Rossi","year":"2008","unstructured":"Rossi GP, Sechi LA, Giacchetti G, Ronconi V, Strazzullo P, Funder JW. Primary aldosteronism: cardiovascular, renal and metabolic implications. Trends Endocrinol Metab. 2008;19:88\u201390.","journal-title":"Trends Endocrinol Metab"},{"key":"112_CR9","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1042\/cs1030425","volume":"103","author":"CA Farquharson","year":"2002","unstructured":"Farquharson CA, Struthers AD. Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy. Clin Sci (Lond). 2002;103:425\u201331.","journal-title":"Clin Sci (Lond)"},{"key":"112_CR10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0272-6386(99)70298-2","volume":"33","author":"M Nishimura","year":"1999","unstructured":"Nishimura M, Uzu T, Fujii T, Kuroda S, Nakamura S, Inenaga T, et al. Cardiovascular complications in patients with primary aldosteronism. Am J Kidney Dis. 1999;33:261\u20136.","journal-title":"Am J Kidney Dis"},{"key":"112_CR11","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1097\/HJH.0000000000000727","volume":"33","author":"J Manolopoulou","year":"2015","unstructured":"Manolopoulou J, Fischer E, Dietz A, Diederich S, Holmes D, Junnila R, et al. Clinical validation for the aldosterone-to-renin ratio and aldosterone suppression testing using simultaneous fully automated chemiluminescence immunoassays. J Hypertens. 2015;33:2500\u201311.","journal-title":"J Hypertens"},{"key":"112_CR12","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1373\/clinchem.2004.033159","volume":"50","author":"FH Perschel","year":"2004","unstructured":"Perschel FH, Schemer R, Seiler L, Reincke M, Deinum J, Maser-Gluth C, et al. Rapid screening test for primary hyperaldosteronism: ratio of plasma aldosterone to renin concentration determined by fully automated chemiluminescence immunoassays. Clin Chem. 2004;50:1650\u20135.","journal-title":"Clin Chem"},{"key":"112_CR13","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/jhh.2017.62","volume":"31","author":"F Pizzolo","year":"2017","unstructured":"Pizzolo F, Salvagno G, Caruso B, Cocco C, Zorzi F, Zaltron C, et al. Fully automated chemiluminescence vs RIA aldosterone assay in primary aldosteronism work-up. J Hum Hypertens. 2017;31:826\u201330.","journal-title":"J Hum Hypertens"},{"key":"112_CR14","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1161\/HYPERTENSIONAHA.117.09078","volume":"70","author":"R Morimoto","year":"2017","unstructured":"Morimoto R, Ono Y, Tezuka Y, Kudo M, Yamamoto S, Arai T, et al. Rapid Screening of primary aldosteronism by a novel chemiluminescent immunoassay. Hypertension. 2017;70:334\u201341.","journal-title":"Hypertension"},{"key":"112_CR15","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1097\/HJH.0000000000000880","volume":"34","author":"J Burrello","year":"2016","unstructured":"Burrello J, Monticone S, Buffolo F, Lucchiari M, Tetti M, Rabbia F, et al. Diagnostic accuracy of aldosterone and renin measurement by chemiluminescent immunoassay and radioimmunoassay in primary aldosteronism. J Hypertens. 2016;34:920\u20137.","journal-title":"J Hypertens"},{"key":"112_CR16","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1210\/jc.2008-0104","volume":"93","author":"JW Funder","year":"2008","unstructured":"Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93:3266\u201381.","journal-title":"J Clin Endocrinol Metab"},{"key":"112_CR17","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1177\/0962280210374532","volume":"20","author":"D Bohning","year":"2011","unstructured":"Bohning D, Holling H, Patilea V. A limitation of the diagnostic-odds ratio in determining an optimal cut-off value for a continuous diagnostic test. Stat Methods Med Res. 2011;20:541\u201350.","journal-title":"Stat Methods Med Res"},{"key":"112_CR18","doi-asserted-by":"publisher","first-page":"R191","DOI":"10.1530\/EJE-14-0537","volume":"172","author":"G Piaditis","year":"2015","unstructured":"Piaditis G, Markou A, Papanastasiou L, Androulakis II, Kaltsas G. Progress in aldosteronism: a review of the prevalence of primary aldosteronism in pre-hypertension and hypertension. Eur J Endocrinol. 2015;172:R191\u2013203.","journal-title":"Eur J Endocrinol"},{"key":"112_CR19","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1097\/HJH.0b013e328360ddf6","volume":"31","author":"X Sang","year":"2013","unstructured":"Sang X, Jiang Y, Wang W, Yan L, Zhao J, Peng Y, et al. Prevalence of and risk factors for primary aldosteronism among patients with resistant hypertension in China. J Hypertens. 2013;31:1465\u201371. discussion71\u20132","journal-title":"J Hypertens"},{"key":"112_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/HJH.0b013e3283656b54","volume":"32","author":"PM Jansen","year":"2014","unstructured":"Jansen PM, van den Born BJ, Frenkel WJ, de Bruijne EL, Deinum J, Kerstens MN, et al. Test characteristics of the aldosterone-to-renin ratio as a screening test for primary aldosteronism. J Hypertens. 2014;32:115\u201326.","journal-title":"J Hypertens"},{"key":"112_CR21","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1210\/jc.2004-1149","volume":"90","author":"SC Tiu","year":"2005","unstructured":"Tiu SC, Choi CH, Shek CC, Ng YW, Chan FK, Ng CM, et al. The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling. J Clin Endocrinol Metab. 2005;90:72\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"112_CR22","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/hr.2014.129","volume":"37","author":"C Nakama","year":"2014","unstructured":"Nakama C, Kamide K, Kawai T, Hongyo K, Ito N, Onishi M, et al. The influence of aging on the diagnosis of primary aldosteronism. Hypertens Res. 2014;37:1062\u20137.","journal-title":"Hypertens Res"},{"key":"112_CR23","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s12020-012-9609-z","volume":"42","author":"G Yin","year":"2012","unstructured":"Yin G, Zhang S, Yan L, Wu M, Xu M, Li F, et al. Effect of age on aldosterone\/renin ratio (ARR) and comparison of screening accuracy of ARR plus elevated serum aldosterone concentration for primary aldosteronism screening in different age groups. Endocrine. 2012;42:182\u20139.","journal-title":"Endocrine"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41371-018-0112-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41371-018-0112-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41371-018-0112-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:23:18Z","timestamp":1684617798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41371-018-0112-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,21]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["112"],"URL":"https:\/\/doi.org\/10.1038\/s41371-018-0112-8","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"value":"0950-9240","type":"print"},{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,21]]},"assertion":[{"value":"26 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}